Greenlight Capital - NEUBASE THERAPEUTICS INC ownership

NEUBASE THERAPEUTICS INC's ticker is NBSE and the CUSIP is 64132K102. A total of 3 filers reported holding NEUBASE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Greenlight Capital ownership history of NEUBASE THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$504,500
-2.7%
2,727,0270.0%0.03%
-25.0%
Q4 2022$518,681
-51.8%
2,727,0270.0%0.04%
-52.6%
Q3 2022$1,077,000
-62.4%
2,727,0270.0%0.08%
-65.9%
Q2 2022$2,863,000
-44.2%
2,727,0270.0%0.22%
-31.6%
Q1 2022$5,127,000
-33.1%
2,727,0270.0%0.33%
-25.6%
Q4 2021$7,663,000
-22.2%
2,727,0270.0%0.44%
-33.6%
Q3 2021$9,844,000
-24.6%
2,727,0270.0%0.66%
-19.5%
Q2 2021$13,062,000
-12.8%
2,727,027
+34.5%
0.82%
-21.4%
Q1 2021$14,980,000
+5.7%
2,027,0270.0%1.04%
+22.4%
Q4 2020$14,169,000
-7.9%
2,027,0270.0%0.85%
-32.2%
Q3 2020$15,386,000
-7.9%
2,027,027
+6.5%
1.26%
-30.7%
Q2 2020$16,711,000
+52.6%
1,903,227
+23.7%
1.81%
+16.1%
Q1 2020$10,954,000
-1.1%
1,538,4620.0%1.56%
+89.9%
Q4 2019$11,077,000
+44.3%
1,538,4620.0%0.82%
+48.9%
Q3 2019$7,677,0001,538,4620.55%
Other shareholders
NEUBASE THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Sio Capital Management, LLC 868,699$4,161,0001.03%
Greenlight Capital 2,727,027$13,062,0000.82%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 345,500$1,655,0000.55%
GSA CAPITAL PARTNERS LLP 346,151$1,658,0000.19%
Tibra Equities Europe Ltd 66,400$318,0000.10%
Opal Wealth Advisors, LLC 20,000$96,0000.09%
Stonepine Capital Management, LLC 31,070$149,0000.08%
Frontier Wealth Management LLC 145,000$695,0000.05%
PRELUDE CAPITAL MANAGEMENT, LLC 311,000$1,490,0000.04%
PERKINS CAPITAL MANAGEMENT INC 14,800$71,0000.04%
View complete list of NEUBASE THERAPEUTICS INC shareholders